X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17688) 17688
Publication (1293) 1293
Book Review (184) 184
Book / eBook (87) 87
Book Chapter (71) 71
Magazine Article (32) 32
Newspaper Article (25) 25
Conference Proceeding (19) 19
Newsletter (19) 19
Dissertation (7) 7
Reference (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14518) 14518
male (7844) 7844
female (7652) 7652
index medicus (5029) 5029
oncology (4456) 4456
adult (4397) 4397
middle aged (4338) 4338
animals (4280) 4280
leukemia (4019) 4019
hematology (3349) 3349
aged (2997) 2997
cancer (2944) 2944
antineoplastic agents - adverse effects (2767) 2767
child (2604) 2604
adolescent (2598) 2598
mice (2446) 2446
chemotherapy (1931) 1931
child, preschool (1766) 1766
antineoplastic combined chemotherapy protocols - adverse effects (1725) 1725
antineoplastic combined chemotherapy protocols - therapeutic use (1458) 1458
antineoplastic agents - therapeutic use (1423) 1423
therapy (1390) 1390
risk factors (1377) 1377
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (1364) 1364
leukemia - chemically induced (1329) 1329
acute lymphoblastic-leukemia (1288) 1288
pharmacology & pharmacy (1206) 1206
acute myeloid-leukemia (1191) 1191
treatment outcome (1163) 1163
acute disease (1127) 1127
apoptosis (1123) 1123
research (1063) 1063
time factors (1012) 1012
leukemia, myeloid, acute - drug therapy (1007) 1007
pediatrics (1005) 1005
neoplasms - drug therapy (992) 992
rats (991) 991
children (977) 977
neutropenia - chemically induced (951) 951
infant (950) 950
dose-response relationship, drug (925) 925
care and treatment (896) 896
health aspects (882) 882
leukemia - drug therapy (867) 867
biochemistry & molecular biology (851) 851
analysis (793) 793
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (756) 756
risk (746) 746
retrospective studies (740) 740
leukemia, myeloid, acute - chemically induced (737) 737
cell biology (709) 709
remission induction (705) 705
follow-up studies (692) 692
article (680) 680
aged, 80 and over (673) 673
expression (653) 653
leukemia, lymphoid - drug therapy (649) 649
toxicology (639) 639
immunology (638) 638
cytarabine - administration & dosage (631) 631
cell line, tumor (627) 627
medicine & public health (625) 625
medicine, general & internal (619) 619
toxicity (617) 617
proteins (615) 615
pyrimidines - adverse effects (607) 607
cytarabine - adverse effects (598) 598
acute promyelocytic leukemia (589) 589
chronic lymphocytic-leukemia (583) 583
methotrexate - adverse effects (572) 572
antineoplastic agents - administration & dosage (565) 565
antineoplastic agents - pharmacology (565) 565
cell line (553) 553
gene expression (536) 536
imatinib mesylate (528) 528
apoptosis - drug effects (525) 525
transplantation (522) 522
chronic myelogenous leukemia (518) 518
tumors (513) 513
prognosis (512) 512
cells (507) 507
thrombocytopenia - chemically induced (503) 503
drug administration schedule (502) 502
public, environmental & occupational health (501) 501
young adult (501) 501
lymphoma (497) 497
neoplasms - chemically induced (495) 495
research article (493) 493
leukemia, myeloid - drug therapy (489) 489
neoplasms, second primary - chemically induced (481) 481
medicine (477) 477
drug therapy (469) 469
incidence (465) 465
leukemia, experimental - chemically induced (465) 465
leukemia, promyelocytic, acute - drug therapy (451) 451
leukemia, lymphocytic, chronic, b-cell - drug therapy (444) 444
stem cells (443) 443
chronic myeloid-leukemia (440) 440
mutation (438) 438
genetic aspects (437) 437
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (76) 76
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
OISE - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Toronto East General Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16301) 16301
German (356) 356
French (313) 313
Japanese (252) 252
Russian (146) 146
Spanish (123) 123
Italian (89) 89
Polish (89) 89
Chinese (64) 64
Dutch (24) 24
Swedish (22) 22
Hungarian (17) 17
Norwegian (12) 12
Portuguese (12) 12
Czech (9) 9
Danish (9) 9
Croatian (7) 7
Romanian (6) 6
Finnish (5) 5
Hebrew (5) 5
Serbian (5) 5
Slovak (4) 4
Ukrainian (4) 4
Bulgarian (3) 3
Korean (2) 2
Turkish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chemical Communications, ISSN 1359-7345, 2017, Volume 53, Issue 54, pp. 7577 - 7580
Cyclin-dependent kinase 9 (CDK9), a member of the cyclindependent protein kinase (CDK) family, is involved in transcriptional elongation of several target... 
INDUCED PROTEIN-DEGRADATION | HUMAN TUMOR XENOGRAFTS | POTENT | UBIQUITIN LIGASE | IN-VIVO | CHRONIC LYMPHOCYTIC-LEUKEMIA | DEPENDENT KINASE INHIBITOR | ANTITUMOR-ACTIVITY | PHASE-I | CHEMISTRY, MULTIDISCIPLINARY | CANCER-THERAPY
Journal Article
Chemical Communications: Chem Comm, ISSN 1359-7345, 07/2017, Volume 53, Issue 54, pp. 7577 - 7580
Cyclin-dependent kinase 9 (CDK9), a member of the cyclin-dependent protein kinase (CDK) family, is involved in transcriptional elongation of several target... 
Degradation | Proteins | Genes | Breast | Kinases | Prostate | Elongation | Cancer
Journal Article
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 07/2013, Volume 63, Issue 4, pp. 249 - 279
Answer questions and earn CME/CNE Advances in genomics and molecular biology have identified aberrant proteins in cancer cells that are attractive targets for... 
toxicity | kinase inhibitors | therapeutic index | targeted agents | mechanism‐based toxicity | immunotherapeutic agents | off‐target toxicity | mechanism-based toxicity | off-target toxicity | MEK INHIBITOR TRAMETINIB | PULMONARY ARTERIAL-HYPERTENSION | I DOSE-ESCALATION | CHRONIC MYELOID-LEUKEMIA | GROWTH-FACTOR RECEPTOR | ONCOLOGY | PLACEBO-CONTROLLED TRIAL | III CLINICAL-TRIAL | SQUAMOUS-CELL CARCINOMAS | TIVANTINIB ARQ 197 | SIGNAL-REGULATED KINASE | Mood Disorders - chemically induced | Drug Eruptions - etiology | Peripheral Nervous System Diseases - chemically induced | Bone Marrow Diseases - chemically induced | Cachexia - chemically induced | Endocrine System Diseases - chemically induced | Pleural Effusion - chemically induced | Humans | Drug Eruptions - therapy | Immune System Diseases - chemically induced | Lung Diseases, Interstitial - chemically induced | Thrombocytopenia - chemically induced | Diarrhea - chemically induced | Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Hyperbilirubinemia - chemically induced | Venous Thromboembolism - chemically induced | Vision Disorders - chemically induced | Hemorrhage - chemically induced | Heart Diseases - chemically induced | Hyperlipidemias - chemically induced | Magnesium - blood | Antimitotic agents | Drugs | Prevention | Complications and side effects | Drug targeting | Antineoplastic agents | Health aspects | Risk factors | Proteins | Side effects | Genomics | Cytotoxicity | Molecular biology | Cancer therapies | Cells | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 200 - 211
Journal Article
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 19, pp. 2944 - 2952
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 27 - 38
Journal Article